全癌症分析KMT2C表达在瘤进展和免疫治疗中的作用
Wei Cao1, Yawen Xie2, Li Cai2,3
1Department of Thoracic Surgery, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, P.R. China.
Oncology letters
|August 2, 2024
概括
基因组氨酸N-甲基转移酶2C (KMT2C) 影响癌症的进展和免疫反应. 低KMT2C预测免疫治疗反应,而高KMT2C促进瘤生长和免疫抑制的微环境.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 基因氨酸N-甲基转移酶2C (KMT2C) 对于基因调节和DNA修复至关重要.
- KMT2C突变与癌症的进展,转移和耐药性有关.
- 在瘤预后和免疫微环境中,KMT2C的确切作用在很大程度上仍未被定义.
研究的目的:
- 研究KMT2C在多种癌症类型中的表达和预后意义.
- 探索KMT2C表达与瘤免疫细胞透和瘤微环境之间的相关性.
- 评估KMT2C水平在癌症治疗中的治疗影响,特别是与免疫疗法相关.
主要方法:
- 利用癌症基因组图谱和基因型-组织表达数据库进行表达分析.
- 执行了Kaplan-Meier,Cox回归和基因组丰富分析 (GSEA) 进行预后和途径分析.
- 使用瘤免疫估计资源2,单样GSEA,斯皮尔曼相关性,免疫组织化学和体外测试 (RNA干扰,伤口愈合,殖民地形成) 来评估免疫相关性和功能影响.
主要成果:
- 在不同癌症中,KMT2C的表达方式各不相同,在脏和卵巢癌中起到保护作用,但在肺癌和卵巢黑色素瘤中起到危险作用.
- KMT2C表达与免疫激活途径和免疫细胞透相反相关,但与免疫抑制因素和瘤血管生成正相关.
- 低KMT2C表达与更高的免疫疗法反应率有关,而KMT2C敲击增强了癌细胞的增殖和入侵.
结论:
- KMT2C表达水平作为预测患者对免疫治疗反应的潜在生物标志物.
- 高KMT2C表达促进瘤血管生成,并有助于免疫抑制瘤微环境.
- 准KMT2C或相关途径可能为特定癌症类型提供新的治疗策略.
更多相关视频
相关概念视频
01:27Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K